BioSpace

Big Pharma is ready to strike, with J&J most likely to buy: Leerink

The largest pharmas have a collective $188 billion in firepower to spend on M&A transactions, with all but one signaling a desire to execute, according to a new analysis from Leerink Partners.

By BioSpace

1 min read
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights